Chen Schor

President & CEO at Adicet Bio Inc.

Sits on 2 boards. Last updated September 28, 2026

Time on boards

Boards served
2
Current seats
2
Board service
7 years
Director since
2023

7 years of board service in total across 2 boards, counting each seat separately. Longest: Adicet Bio Inc., 3 years.

Adicet Bio Inc. Director · President & CEO
3 years · Since 2023
3 years · Since 2023

Chief executive roles

Adicet Bio Inc. · President & CEO
Dates unknown

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
May 21, 2026 Karyopharm Therapeutics Inc. Grant or award +15,508 — —
Jan 24, 2026 Adicet Bio Inc. Shares withheld for tax −1,755 $8.44 $14,812
Jan 24, 2025 Adicet Bio Inc. Shares withheld for tax −28,101 $0.92 $25,853
Jan 24, 2024 Adicet Bio Inc. Shares withheld for tax −15,290 $2.40 $36,696
Jan 24, 2024 Adicet Bio Inc. Grant or award +70,300 — —
Oct 2, 2023 Adicet Bio Inc. Open-market purchase +5,500 $1.33 $7,315
Oct 2, 2023 Adicet Bio Inc. Shares withheld for tax −23,208 $1.37 $31,795
Sep 29, 2023 Adicet Bio Inc. Open-market sale −5,500 $1.36 $7,480
Sep 28, 2023 Adicet Bio Inc. Open-market sale −5,500 $1.42 $7,810
Sep 28, 2023 Adicet Bio Inc. Open-market purchase +5,500 $1.42 $7,810
Jan 24, 2023 Adicet Bio Inc. Grant or award +85,500 — —
Nov 14, 2022 Adicet Bio Inc. Gift −9,955 — —
Nov 14, 2022 Adicet Bio Inc. Gift +9,955 — —
Oct 17, 2022 Adicet Bio Inc. Gift −26,712 — —
Oct 17, 2022 Adicet Bio Inc. Gift +26,712 — —

Questions about Chen Schor

What boards is Chen Schor on?

Chen Schor sits on the boards of Adicet Bio Inc. and Karyopharm Therapeutics Inc.

What company is Chen Schor the CEO of?

Chen Schor is President & CEO of Adicet Bio Inc.

How long has Chen Schor served on boards?

Our records show at least 7 years of board service across 2 boards, the earliest from 2023.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.